If you need more lookups,
subscriptions start at $34 USD/month.
Ed Christian Location
Cambridge, MA, US
Ed Christian Work
2021 -now Executive Director Clinical Sciences @
2019 -2021 Executive Director, Translational Medicine @ Cadent Therapeutics
2017 -2019 Consultant and Advisor in Translational Neuroscience to innovative CNS drug development companies @ multiple corporations
2016 -2016 Exploring a CNS Based Start-Up Venture @ Independent Consultant Translational Neuroscience
2014 -2016 Consultant @
2013 -2014 Translational science consultant @
2011 -2013 Director of Electrophysiology @
2006 -2011 Senior Principal Neuroscientist @
2000 -2006 Principal Neuroscientist @
1990 -2000 Laboratory Director @
Ed Christian Education
Wake Forest University School of Medicine
PhD (Physiology / Neuroscience / Pharmacology)
Ed Christian Skills
Neuroscience
Pharmacology
Drug Discovery
Drug Development
Ion Channels
Electrophysiology
in Vivo Electrophysiology
Translational Medicine
translational neuroscience research
systems neuroscience
Biomarkers
in vitro electrophysiology
Biotechnology
Neurology
Pharmacodynamics
Pharmacokinetics
Life Sciences
Clinical Development
Microsoft Office
Drug Design
Cell
Scientists
Data Analysis
Program Management
In Vivo
High Throughput Screening
In Vitro
Research
Cell Culture
Strategic Planning
Clinical Research
Lead Change
Ed Christian Summary
Ed Christian, based in Cambridge, MA, US, is currently a Executive Director Clinical Sciences at Gilgamesh Pharmaceuticals. Ed Christian brings experience from previous roles at Cadent Therapeutics, multiple corporations, Independent Consultant Translational Neuroscience and FORUM Pharmaceuticals (formerly Envivo Pharmaceuticals). Ed Christian holds a PhD in Physiology / Neuroscience / Pharmacology @ Wake Forest University School of Medicine. With a robust skill set that includes Neuroscience, Pharmacology, Drug Discovery, Drug Development, Ion Channels and more. Ed Christian has 1 emails on RocketReach.
Looking for a different Ed Christian?
Find contact details for 700 million professionals.